NCT05166629Active, not recruiting
Eatable Alphabet as a Nutrition Education Tool
Measuring the Effectiveness of Eatable Alphabet Cards as a Nutrition Education Tool in a Pediatric Weight Management Program
Source: ClinicalTrials.gov · Last updated 9 Jun 2026
Brief summary (registry, in English)
This pilot randomized controlled trial will test the effectiveness of Eatable Alphabet cards, a child friendly nutrition education tool, on child weight and related behaviors in a clinical sample of 2 to 10-year-old children with overweight/obesity, referred to a pediatric weight management program.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- First submitted
- 3 Dec 2021
- Start date
- 1 Sept 2023
- Primary completion date
- 15 Sept 2026
- Lead sponsor
- Northwell Health
- Diseases
- Obesity
- NCT number
- NCT05166629
What you commit to
- Study type: Interventional
- Planned participants: 160
- From 1 Sept 2023 to the primary completion date, 15 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- No appropriate caregiver available for consent.
Who the study is looking for
- New patient at Cohen Children's Medical Center POWER Kids weight management program (defined as not having been seen by the program within the past 2 years)
- Child between the ages of 2-10
- English-speaking
Age in the registry: 2 years to 10 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cohen Children's Medical Center Coordinator of this site? Confirm its status | New Hyde Park | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.